serw-MX  [xml]  

 DeCS Categories

C04 Neoplasms .
C04.445 Hamartoma .
C04.445.622 Pallister-Hall Syndrome .
C04.588 Neoplasms by Site .
C04.588.614 Nervous System Neoplasms .
C04.588.614.250 Central Nervous System Neoplasms .
C04.588.614.250.195 Brain Neoplasms .
C04.588.614.250.195.885 Supratentorial Neoplasms .
C04.588.614.250.195.885.500 Hypothalamic Neoplasms .
C04.588.614.250.195.885.500.299 Pallister-Hall Syndrome .
C05 Musculoskeletal Diseases .
C05.660 Musculoskeletal Abnormalities .
C05.660.585 Limb Deformities, Congenital .
C05.660.585.600 Polydactyly .
C05.660.585.600.374 Pallister-Hall Syndrome .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.211 Brain Neoplasms .
C10. Supratentorial Neoplasms .
C10. Hypothalamic Neoplasms .
C10. Pallister-Hall Syndrome .
C10.228.140.617 Hypothalamic Diseases .
C10.228.140.617.477 Hypothalamic Neoplasms .
C10.228.140.617.477.299 Pallister-Hall Syndrome .
C10.551 Nervous System Neoplasms .
C10.551.240 Central Nervous System Neoplasms .
C10.551.240.250 Brain Neoplasms .
C10.551.240.250.700 Supratentorial Neoplasms .
C10.551.240.250.700.500 Hypothalamic Neoplasms .
C10.551.240.250.700.500.249 Pallister-Hall Syndrome .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.131 Congenital Abnormalities .
C16.131.077 Abnormalities, Multiple .
C16.131.077.690 Pallister-Hall Syndrome .
C16.131.621 Musculoskeletal Abnormalities .
C16.131.621.585 Limb Deformities, Congenital .
C16.131.621.585.600 Polydactyly .
C16.131.621.585.600.374 Pallister-Hall Syndrome .
D02 Organic Chemicals .
D02.626 Nitriles .
D02.626.809 Rilpivirine .
D02.626.809.500 Emtricitabine, Rilpivirine, Tenofovir Drug Combination .
D02.705 Organophosphorus Compounds .
D02.705.429 Organophosphonates .
D02.705.429.906 Tenofovir .
D02.705.429.906.500 Emtricitabine, Rilpivirine, Tenofovir Drug Combination .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.742 Pyrimidines .
D03.383.742.680 Pyrimidine Nucleosides .
D03.383.742.680.245 Cytidine .
D03.383.742.680.245.500 Deoxycytidine .
D03.383.742.680.245.500.600 Emtricitabine .
D03.383.742.680.245.500.600.500 Emtricitabine, Rilpivirine, Tenofovir Drug Combination .
D03.383.742.755 Rilpivirine .
D03.383.742.755.500 Emtricitabine, Rilpivirine, Tenofovir Drug Combination .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.759 Purines .
D03.633.100.759.138 Adenine .
D03.633.100.759.138.881 Tenofovir .
D03.633.100.759.138.881.500 Emtricitabine, Rilpivirine, Tenofovir Drug Combination .
D05 Macromolecular Substances .
D05.500 Multiprotein Complexes .
D05.500.562 Multienzyme Complexes .
D05.500.562.750 Succinate Cytochrome c Oxidoreductase .
D05.500.562.750.500 Electron Transport Complex III .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.600 Multienzyme Complexes .
D08.811.600.250 Electron Transport Chain Complex Proteins .
D08.811.600.250.875 Succinate Cytochrome c Oxidoreductase .
D08.811.600.250.875.500 Electron Transport Complex III .
D08.811.682 Oxidoreductases .
D08.811.682.830 Succinate Cytochrome c Oxidoreductase .
D08.811.682.830.500 Electron Transport Complex III .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.124 Blood Proteins .
D12.776.124.486 Immunoproteins .
D12.776.124.486.274 Complement System Proteins .
D12.776.124.486.274.930 Complement Membrane Attack Complex .
D12.776.157 Carrier Proteins .
D12.776.157.427 Iron-Binding Proteins .
D12.776.157.427.374 Nonheme Iron Proteins .
D12.776.157.427.374.375 Iron-Sulfur Proteins .
D12.776.157.427.374.375.954 Electron Transport Complex III .
D12.776.157.530 Membrane Transport Proteins .
D12.776.157.530.450 Ion Pumps .
D12.776.157.530.450.250 Cation Transport Proteins .
D12.776.157.530.450.250.875 Proton Pumps .
D12.776.157.530.450.250.875.303 Electron Transport Complex III .
D12.776.543 Membrane Proteins .
D12.776.543.277 Electron Transport Chain Complex Proteins .
D12.776.543.277.875 Succinate Cytochrome c Oxidoreductase .
D12.776.543.277.875.500 Electron Transport Complex III .
D12.776.543.585 Membrane Transport Proteins .
D12.776.543.585.450 Ion Pumps .
D12.776.543.585.450.250 Cation Transport Proteins .
D12.776.543.585.450.250.875 Proton Pumps .
D12.776.543.585.450.250.875.468 Electron Transport Complex III .
D12.776.556 Metalloproteins .
D12.776.556.579 Iron-Binding Proteins .
D12.776.556.579.374 Nonheme Iron Proteins .
D12.776.556.579.374.375 Iron-Sulfur Proteins .
D12.776.556.579.374.375.142 Electron Transport Complex III .
D26 Pharmaceutical Preparations .
D26.310 Drug Combinations .
D26.310.407 Emtricitabine, Rilpivirine, Tenofovir Drug Combination .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.914 Sequestering Agents .
D27.505.519.914.500 Chelating Agents .
D27.720 Specialty Uses of Chemicals .
D27.720.832 Sequestering Agents .
D27.720.832.500 Chelating Agents .
HP3 Homeopathic Therapeutics .
HP3.106 Therapeutic Approaches .
HP3.106.566 Pluralism (Homeopathy) .
HP3.106.566.219 Complexism .
 Synonyms & Historicals
Chelating Agents .
Chelators .
Metal Chelating Agents .
Agents, Chelating .
Agents, Metal Chelating .
Antagonists, Metal .
Chelating Agents, Metal .
Complexons .
Metal Antagonists .
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. .
Complexism .
Therapeutical approach that simultaneously combines various homeopathic remedies in the same bottle. These compounds are used for treating a particular illness without having been tested on healthy humans. .
Emtricitabine, Rilpivirine, Tenofovir Drug Combination .
Complera .
Emtricitabine Rilpivirine Tenofovir Drug Combination .
Emtricitabine-Rilpivirine-Tenofovir Drug Combination .
Combination, Emtricitabine-Rilpivirine-Tenofovir Drug .
Drug Combination, Emtricitabine-Rilpivirine-Tenofovir .
A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS. .
Complement System Proteins .
Complement .
Complement Protein .
Hemolytic Complement .
Complement, Hemolytic .
Protein, Complement .
Proteins, Complement .
Proteins, Complement System .
Complement Proteins .
Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). .
Complement Membrane Attack Complex .
C 5b-9 .
C5b-8-poly-C9 .
C5b-9 .
Cytolytic Terminal Complement Complex .
Terminal Complement Complex .
C5b 8 poly C9 .
Complement Complex C5b 9 .
Complement Complex, Terminal .
Complex, Terminal Complement .
Membrane Attack Complex .
Complement Complex C5b-9 .
A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components (COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9) into the target membrane. The resultant C5b-8-poly-C9 is the "membrane attack complex" or MAC. .
Electron Transport Complex III .
Coenzyme Q-Cytochrome-c Reductase .
Coenzyme QH2-Cytochrome-c Reductase .
Core I Protein, UCCreductase .
Core I Protein, Ubiquinol-Cytochrome c Reductase .
Core II Protein, UCCreductase .
Core II Protein, Ubiquinol-Cytochrome c Reductase .
Cytochrome b-c2 Oxidoreductase .
Cytochrome bc1 .
Dihydroubiquinone-Cytochrome-c Reductase .
QH(2)-Cytochrome-c Reductase .
QH(2)-Ferricytochrome-c Oxidoreductase .
Ubihydroquinone-Cytochrome-c Reductase .
Ubiquinol-Cytochrome c Reductase .
Ubiquinone-Cytochrome b-c2 Oxidoreductase .
Coenzyme Q Cytochrome c Reductase .
Coenzyme QH2 Cytochrome c Reductase .
Core I Protein, Ubiquinol Cytochrome c Reductase .
Core II Protein, Ubiquinol Cytochrome c Reductase .
Cytochrome b c2 Oxidoreductase .
Dihydroubiquinone Cytochrome c Reductase .
Reductase, Ubiquinol-Cytochrome c .
Ubihydroquinone Cytochrome c Reductase .
Ubiquinol Cytochrome c Reductase .
Ubiquinone Cytochrome b c2 Oxidoreductase .
Complex III .
Cytochrome bc1 Complex .
Ubiquinol-Cytochrome-c Reductase .
A multisubunit enzyme complex that contains CYTOCHROME B GROUP; CYTOCHROME C1; and iron-sulfur centers. It catalyzes the oxidation of ubiquinol to UBIQUINONE, and transfers the electrons to CYTOCHROME C. In MITOCHONDRIA the redox reaction is coupled to the transport of PROTONS across the inner mitochondrial membrane. .
Pallister-Hall Syndrome .
CAVE Complex .
Cerebroacrovisceral Early Lethality Complex .
Hall-Pallister Syndrome .
Hypothalamic Hamartoblastoma Syndrome .
Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly .
CAVE Complices .
Complex, CAVE .
Complices, CAVE .
Hall Pallister Syndrome .
Hamartoblastoma Syndrome, Hypothalamic .
Hamartoblastoma Syndromes, Hypothalamic .
Hypothalamic Hamartoblastoma Syndromes .
Pallister Hall Syndrome .
Syndrome, Hall-Pallister .
Syndrome, Hypothalamic Hamartoblastoma .
Syndrome, Pallister-Hall .
Syndromes, Hypothalamic Hamartoblastoma .
A pleiotropic disorder of human development that comprises hypothalamic HAMARTOMA; central and postaxial POLYDACTYLY; bifid EPIGLOTTIS; ANAL ATRESIA; and renal and other abnormalities. This disorder is associated with FRAMESHIFT MUTATIONS in the GLI3 gene which encodes the GLI3 protein, a KRUPPEL-LIKE TRANSCRIPTION FACTORS family member. .